Dietary SCFAs Immunotherapy: Reshaping the Gut Microbiota in Diabetes.
2020
Diet-microbiota related inflammatory conditions such as obesity, autoimmune type 1 diabetes (T1D), type 2 diabetes (T2D), cardiovascular disease (CVD) and gut infections have become a stigma in Western societies and developing nations. This book chapter examines the most relevant pre-clinical and clinical studies about diet-gut microbiota approaches as an alternative therapy for diabetes. We also discuss what we and others have extensively investigated- the power of dietary short-chain fatty acids (SCFAs) technology that naturally targets the gut microbiota as an alternative method to prevent and treat diabetes and its related complications.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
175
References
4
Citations
NaN
KQI